Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast Cancer-Reference-Cited by-同舟云学术

Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast Cancer

Published:2018-02 Issue:1 Volume:18 Page:e89-e95
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Osborne Cynthia,Challagalla Jagathi D.,Eisenbeis Charles F.,Holmes Frankie Ann,Neubauer Marcus A.,Koutrelakos Nicholas W.,Taboada Carlos A.,Vukelja Sasha J.,Wilks Sharon T.,Allison Mary Ann,Reddy Praveen,Sedlacek Scot,Wang Yunfei,Asmar Lina,O’Shaughnessy Joyce

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years;Tevaarwerk;Cancer,2013

2. Ixabepilone: clinical role in metastatic breast cancer;Denduluri;Clin Breast Cancer,2011

3. Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine;Perez;J Clin Oncol,2007

4. Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy;Roché;J Clin Oncol,2007

5. Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancer;Thomas;J Clin Oncol,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing the Efficacy and Safety of Chemotherapy Plus Everolimus in HER2-Negative Metastatic Breast Cancer Harboring Altered PI3K/AKT/mTOR;Discovery Medicine;2024

2. Roles of Protein Disulfide Isomerase in Breast Cancer;Cancers;2022-01-31

3. Ixabepilone: Overview of Effectiveness, Safety, and Tolerability in Metastatic Breast Cancer;Frontiers in Oncology;2021-07-06

4. Mitotic Poisons in Research and Medicine;Molecules;2020-10-12

5. Vorinostat-loaded titanium oxide nanoparticles (anatase) induce G2/M cell cycle arrest in breast cancer cells via PALB2 upregulation;3 Biotech;2020-08-27